Cytomegalovirus as an immunomodulator across the lifespan.

[1]  M. Lederman,et al.  Cytomegalovirus Coinfection Is Associated with Increased Vascular-Homing CD57+ CD4 T Cells in HIV Infection , 2020, The Journal of Immunology.

[2]  S. Jonjić,et al.  Modulation of innate and adaptive immunity by cytomegaloviruses , 2019, Nature Reviews Immunology.

[3]  R. Xavier,et al.  Targeting innate immunity for tuberculosis vaccination. , 2019, The Journal of clinical investigation.

[4]  J. Cohen,et al.  Human cytomegalovirus evades antibody-mediated immunity through endoplasmic reticulum-associated degradation of the FcRn receptor , 2019, Nature Communications.

[5]  Joseph C. Sun,et al.  Cytomegalovirus Infection Drives Avidity Selection of Natural Killer Cells. , 2019, Immunity.

[6]  J. Wiemels,et al.  Early Infection with Cytomegalovirus and Risk of Childhood Hematologic Malignancies , 2019, Cancer Epidemiology, Biomarkers & Prevention.

[7]  C. James,et al.  Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis , 2019, The Journal of clinical investigation.

[8]  N. Goonetilleke,et al.  Human cytomegalovirus-vectored vaccines against HIV , 2019, Current opinion in HIV and AIDS.

[9]  P. Griffiths,et al.  Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta‐analysis , 2019, Reviews in medical virology.

[10]  Marc Schleiss,et al.  Cytomegalovirus , 2019, Adult-Gerontology Practice Guidelines.

[11]  M. Vignali,et al.  Cytomegalovirus Exposure in the Elderly Does Not Reduce CD8 T Cell Repertoire Diversity , 2018, The Journal of Immunology.

[12]  D. Barouch,et al.  CMV Primes Functional Alternative Signaling in Adaptive Δg NK Cells but Is Subverted by Lentivirus Infection in Rhesus Macaques , 2018, Cell reports.

[13]  B. Herold,et al.  A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection , 2018, npj Vaccines.

[14]  M. Maeurer,et al.  The impact of inflationary cytomegalovirus‐specific memory T cells on anti‐tumour immune responses in patients with cancer , 2018, Immunology.

[15]  C. Benedict,et al.  Cytomegalovirus: Shape-Shifting the Immune System , 2018, The Journal of Immunology.

[16]  C. S. Nelson,et al.  HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions , 2018, Proceedings of the National Academy of Sciences.

[17]  Mark M Davis,et al.  Rebooting Human Immunology. , 2018, Annual review of immunology.

[18]  J. Walter,et al.  Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells , 2018, Nature Immunology.

[19]  G. Asiki,et al.  Human cytomegalovirus epidemiology and relationship to tuberculosis and cardiovascular disease risk factors in a rural Ugandan cohort , 2018, PloS one.

[20]  S. Plotkin,et al.  Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections , 2018, Journal of Virology.

[21]  S. Jonjić,et al.  CMV and natural killer cells: shaping the response to vaccination , 2018, European journal of immunology.

[22]  L. Picker,et al.  CD8+ T cell programming by cytomegalovirus vectors: applications in prophylactic and therapeutic vaccination. , 2017, Current opinion in immunology.

[23]  J. V. van Dongen,et al.  Ageing and latent CMV infection impact on maturation, differentiation and exhaustion profiles of T-cell receptor gammadelta T-cells , 2017, Scientific Reports.

[24]  M. Teixeira,et al.  Aged-associated cytomegalovirus and Epstein-Barr virus reactivation and cytomegalovirus relationship with the frailty syndrome in older women , 2017, PloS one.

[25]  Kecheng Huang,et al.  Cytomegalovirus Infection and Relative Risk of Cardiovascular Disease (Ischemic Heart Disease, Stroke, and Cardiovascular Death): A Meta‐Analysis of Prospective Studies Up to 2016 , 2017, Journal of the American Heart Association.

[26]  A. Souquette,et al.  A constant companion: immune recognition and response to cytomegalovirus with aging and implications for immune fitness , 2017, GeroScience.

[27]  E. Delwart,et al.  In utero cytomegalovirus infection and development of childhood acute lymphoblastic leukemia. , 2017, Blood.

[28]  A. Larbi,et al.  CMV induces expansion of highly polyfunctional CD4+ T cell subset coexpressing CD57 and CD154 , 2017, Journal of leukocyte biology.

[29]  Mark M. Davis,et al.  Phylogenetic analysis of the human antibody repertoire reveals quantitative signatures of immune senescence and aging , 2017, Proceedings of the National Academy of Sciences.

[30]  J. Grivel,et al.  Cytomegalovirus‐Productive Infection Is Associated With Acute Coronary Syndrome , 2016, Journal of the American Heart Association.

[31]  P. Klenerman,et al.  T cell responses to cytomegalovirus , 2016, Nature Reviews Immunology.

[32]  V. Appay,et al.  Coordinated expansion of both memory T cells and NK cells in response to CMV infection in humans , 2016, European journal of immunology.

[33]  P. Brodin,et al.  Immune Adaptation to Environmental Influence: The Case of NK Cells and HCMV. , 2016, Trends in immunology.

[34]  J. Ernerudh,et al.  Humoral response to influenza vaccination in relation to pre-vaccination antibody titres, vaccination history, cytomegalovirus serostatus and CD4/CD8 ratio , 2016, Infectious diseases.

[35]  C. Cobbs,et al.  Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma. , 2015, Cancer research.

[36]  K. Cadwell.  The virome in host health and disease. , 2015, Immunity.

[37]  Mark M. Davis,et al.  Cytomegalovirus infection enhances the immune response to influenza , 2015, Science Translational Medicine.

[38]  A. Díaz,et al.  Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine. , 2015, Vaccine.

[39]  A. Muntasell,et al.  Dynamics of the NK-cell subset redistribution induced by cytomegalovirus infection in preterm infants. , 2015, Human immunology.

[40]  Atul J. Butte,et al.  Variation in the Human Immune System Is Largely Driven by Non-Heritable Influences , 2015, Cell.

[41]  S. Grosse,et al.  Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[42]  F. Locatelli,et al.  Human Cytomegalovirus Infection Promotes Rapid Maturation of NK Cells Expressing Activating Killer Ig–like Receptor in Patients Transplanted with NKG2C−/− Umbilical Cord Blood , 2014, The Journal of Immunology.

[43]  A. Larbi,et al.  CMV Latent Infection Improves CD8+ T Response to SEB Due to Expansion of Polyfunctional CD57+ Cells in Young Individuals , 2014, PloS one.

[44]  Mark M. Davis,et al.  Effects of Aging, Cytomegalovirus Infection, and EBV Infection on Human B Cell Repertoires , 2014, The Journal of Immunology.

[45]  T. Tötterman,et al.  Cytomegalovirus‐Specific CD4 and CD8 T Cell Responses in Infants and Children , 2013, Scandinavian journal of immunology.

[46]  P. van Damme,et al.  Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination. , 2013, Vaccine.

[47]  V. Emery,et al.  The “Silent” Global Burden of Congenital Cytomegalovirus , 2013, Clinical Microbiology Reviews.

[48]  S. Sharp,et al.  Higher immunoglobulin G antibody levels against cytomegalovirus are associated with incident ischemic heart disease in the population-based EPIC-Norfolk cohort. , 2012, The Journal of infectious diseases.

[49]  A. Muntasell,et al.  Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK‐cell subset distribution in children , 2012, European journal of immunology.

[50]  Jeffrey S. Miller,et al.  Human Cytomegalovirus (CMV)-Induced Memory-like NKG2C+ NK Cells Are Transplantable and Expand In Vivo in Response to Recipient CMV Antigen , 2012, The Journal of Immunology.

[51]  K. Rosenzweig,et al.  No consistent relationship of glioblastoma incidence and cytomegalovirus seropositivity in whites, blacks, and Hispanics. , 2012, Anticancer research.

[52]  Suzanne P. M. Welten,et al.  Memory T cell inflation: understanding cause and effect. , 2012, Trends in immunology.

[53]  K. Puopolo,et al.  Maternal cytomegalovirus-specific immune responses and symptomatic postnatal cytomegalovirus transmission in very low-birth-weight preterm infants. , 2011, The Journal of infectious diseases.

[54]  P. J. Norris,et al.  Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection , 2011, Proceedings of the National Academy of Sciences.

[55]  R. Westendorp,et al.  Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities. , 2011, Vaccine.

[56]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[57]  J. Dowd,et al.  Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. , 2010, American journal of epidemiology.

[58]  R. González-Amaro,et al.  Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children , 2010, European journal of immunology.

[59]  M. Goldman,et al.  Human cytomegalovirus elicits fetal γδ T cell responses in utero , 2010, The Journal of experimental medicine.

[60]  W. Britt,et al.  Cytomegalovirus reinfections in healthy seroimmune women. , 2010, The Journal of infectious diseases.

[61]  L. Rassenti,et al.  Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia , 2009, European journal of clinical investigation.

[62]  P. Moss,et al.  Cytomegalovirus‐seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals , 2009, Clinical and experimental immunology.

[63]  J. Moreau,et al.  Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection. , 2008, Blood.

[64]  S. Rowland-Jones,et al.  Maintenance of Large Subpopulations of Differentiated CD8 T-Cells Two Years after Cytomegalovirus Infection in Gambian Infants , 2008, PloS one.

[65]  S. Rowland-Jones,et al.  CD4(+) T cell responses to cytomegalovirus in early life: a prospective birth cohort study. , 2008, The Journal of infectious diseases.

[66]  R. McLendon,et al.  Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. , 2008, Neuro-oncology.

[67]  C. Franceschi,et al.  Massive Load of Functional Effector CD4+ and CD8+ T Cells against Cytomegalovirus in Very Old Subjects1 , 2007, The Journal of Immunology.

[68]  S. Grosse,et al.  New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection , 2007, Reviews in medical virology.

[69]  M. Cannon,et al.  Review and meta‐analysis of the epidemiology of congenital cytomegalovirus (CMV) infection , 2007, Reviews in medical virology.

[70]  M. Somasundaran,et al.  Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants. , 2007, The Journal of infectious diseases.

[71]  M. Diamond,et al.  Herpesvirus latency confers symbiotic protection from bacterial infection , 2007, Nature.

[72]  Steve Kaye,et al.  Cytomegalovirus Infection in Gambian Infants Leads to Profound CD8 T-Cell Differentiation , 2007, Journal of Virology.

[73]  A. Angulo,et al.  Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. , 2006, Blood.

[74]  G. Pawelec,et al.  T-cell dysregulation caused by chronic antigenic stress: the role of CMV in immunosenescence? , 2006, Aging clinical and experimental research.

[75]  C. Söderberg-Nauclér,et al.  Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? , 2006, Journal of internal medicine.

[76]  L. Picker,et al.  Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects , 2005, The Journal of experimental medicine.

[77]  R. Würzner,et al.  Long-Term Cytomegalovirus Infection Leads to Significant Changes in the Composition of the CD8+ T-Cell Repertoire, Which May Be the Basis for an Imbalance in the Cytokine Production Profile in Elderly Persons , 2005, Journal of Virology.

[78]  P. Moss,et al.  Herpesvirus-Specific CD8 T Cell Immunity in Old Age: Cytomegalovirus Impairs the Response to a Coresident EBV Infection1 , 2004, The Journal of Immunology.

[79]  N. Malats,et al.  Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. , 2004, Blood.

[80]  G. Pawelec,et al.  Is immunosenescence infectious? , 2004, Trends in immunology.

[81]  P. Moss,et al.  CD8(+) T-cell immunity to cytomegalovirus. , 2004, Human immunology.

[82]  H. Maecker,et al.  Persistent and Selective Deficiency of CD4+ T Cell Immunity to Cytomegalovirus in Immunocompetent Young Children1 , 2004, The Journal of Immunology.

[83]  D. Lilleri,et al.  Human Cytomegalovirus Proteins pp65 and Immediate Early Protein 1 Are Common Targets for CD8+ T Cell Responses in Children with Congenital or Postnatal Human Cytomegalovirus Infection1 , 2004, The Journal of Immunology.

[84]  J. Myśliwska,et al.  Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination--an impact of immunosenescence. , 2003, Vaccine.

[85]  G. Pawelec,et al.  Large Numbers of Dysfunctional CD8+ T Lymphocytes Bearing Receptors for a Single Dominant CMV Epitope in the Very Old , 2003, Journal of Clinical Immunology.

[86]  S. Rowland-Jones,et al.  Mature CD8(+) T lymphocyte response to viral infection during fetal life. , 2003, The Journal of clinical investigation.

[87]  R. Champlin,et al.  Cytomegalovirus seropositivity is significantly associated with mycosis fungoides and Sézary syndrome. , 2003, Blood.

[88]  B. Johansson,et al.  Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study , 2002, Experimental Gerontology.

[89]  B. Johansson,et al.  Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study , 2001, Mechanisms of Ageing and Development.

[90]  C. Cobbs,et al.  Cytomegalovirus as an oncomodulatory agent in the progression of glioma. , 2017, Cancer letters.